{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:47:48Z","timestamp":1790430468072,"version":"4.1.0"},"reference-count":49,"publisher":"Impact Journals, LLC","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2106,7,5]]},"DOI":"10.18632\/oncotarget.9630","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T21:20:33Z","timestamp":1464297633000},"page":"41913-41928","source":"Crossref","is-referenced-by-count":19,"title":["Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma"],"prefix":"10.18632","volume":"7","author":[{"given":"Katy","family":"Mastorci","sequence":"first","affiliation":[{"name":"Cancer Bio-Immunotherapy Unit, Department of Translational Research, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano (PN), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Montico","sequence":"additional","affiliation":[{"name":"Cancer Bio-Immunotherapy Unit, Department of Translational Research, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano (PN), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiana A.","family":"Fa\u00e8","sequence":"additional","affiliation":[{"name":"Cancer Bio-Immunotherapy Unit, Department of Translational Research, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano (PN), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sigalotti","sequence":"additional","affiliation":[{"name":"Cancer Bio-Immunotherapy Unit, Department of Translational Research, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano (PN), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Vita-Salute University San Raffaele, Pathology Unit and Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"Department of Pathology and CeRMS, University of Torino, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dolcetti","sequence":"additional","affiliation":[{"name":"Cancer Bio-Immunotherapy Unit, Department of Translational Research, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano (PN), Italy"},{"name":"The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Dal","family":"Col","sequence":"additional","affiliation":[{"name":"Cancer Bio-Immunotherapy Unit, Department of Translational Research, Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano (PN), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma","volume":"84","author":"Rozman","year":"1994","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.2003.04761.x","article-title":"Molecular basis of mantle cell lymphoma","volume":"124","author":"Cotter","year":"2004","journal-title":"British journal of haematology"},{"key":"3","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Moroy","year":"1994","journal-title":"The EMBO journal"},{"key":"4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/leu.2008.213","article-title":"Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2","volume":"22","author":"Quintanilla-Martinez","year":"2008","journal-title":"Leukemia"},{"key":"5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2141.2005.05630.x","article-title":"Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways","volume":"130","author":"Zago","year":"2005","journal-title":"British journal of haematology"},{"key":"6","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","article-title":"Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma","volume":"108","author":"Raffeld","year":"2006","journal-title":"Blood"},{"key":"7","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","article-title":"Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma","volume":"111","author":"Dolcetti","year":"2008","journal-title":"Blood"},{"key":"8","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Campo","year":"2012","journal-title":"The Journal of clinical investigation"},{"key":"9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2014-05-521898","article-title":"Mantle cell lymphoma: evolving management strategies","volume":"125","author":"Rule","year":"2015","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1158\/1078-0432.CCR-15-0488","article-title":"Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice","volume":"21","author":"Goy","year":"2015","journal-title":"Clinical cancer research"},{"key":"11","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Oscier","year":"2003","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.2008.19.6121","article-title":"Outcome of deferred initial therapy in mantle-cell lymphoma","volume":"27","author":"Leonard","year":"2009","journal-title":"Journal of clinical oncology"},{"key":"13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s40266-013-0129-1","article-title":"Management of mantle cell lymphoma in the elderly: current and potential strategies","volume":"30","author":"Delarue","year":"2013","journal-title":"Drugs & aging"},{"key":"14","first-page":"e17","article-title":"Clinical efficacy and safety in relapsed\/refractory mantle cell lymphoma: a systematic literature review","volume":"15","author":"Awan","year":"2015","journal-title":"Clinical lymphoma, myeloma & leukemia"},{"key":"15","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1200\/jco.2006.24.18_suppl.7512","article-title":"Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma","volume":"24","author":"Goy","year":"2006","journal-title":"Journal of clinical oncology"},{"key":"16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1412096","article-title":"Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma","volume":"372","author":"Okamoto","year":"2015","journal-title":"The New England journal of medicine"},{"key":"17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bjh.13101","article-title":"Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma","volume":"168","author":"Rule","year":"2015","journal-title":"British journal of haematology"},{"key":"18","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3109\/10428190903207548","article-title":"Exploring mammalian target of rapamycin (mTOR) inhibition for treatment of mantle cell lymphoma and other hematologic malignancies","volume":"50","author":"Ribrag","year":"2009","journal-title":"Leukemia & lymphoma"},{"key":"19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-015-0006-1","article-title":"Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis","volume":"4","author":"Moran","year":"2015","journal-title":"Experimental hematology & oncology"},{"key":"20","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1158\/1078-0432.CCR-12-0351","article-title":"Counteracting autophagy overcomes resistance to everolimus in mantle cell lymphoma","volume":"18","author":"Roue","year":"2012","journal-title":"Clinical cancer research"},{"key":"21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.drup.2014.12.001","article-title":"Molecular basis of resistance to proteasome inhibitors in hematological malignancies","volume":"18","author":"Cloos","year":"2015","journal-title":"Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy"},{"key":"22","first-page":"37","article-title":"Crosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer","volume":"6","author":"Hassan","year":"2013","journal-title":"Journal of cell death"},{"key":"23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: the interplay of autophagy and apoptosis","volume":"15","author":"Kroemer","year":"2014","journal-title":"Nature reviews Molecular cell biology"},{"key":"24","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1158\/0008-5472.CAN-11-2505","article-title":"Retinoic acid\/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets","volume":"72","author":"Dolcetti","year":"2012","journal-title":"Cancer research"},{"key":"25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4161\/auto.6.8.13793","article-title":"Autophagy: a target for retinoic acids","volume":"6","author":"Bossis","year":"2010","journal-title":"Autophagy"},{"key":"26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/jir.2013.0128","article-title":"New function of type I IFN: induction of autophagy","volume":"34","author":"Zoon","year":"2014","journal-title":"Journal of interferon & cytokine research"},{"key":"27","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1182\/blood.V95.8.2593","article-title":"Transcriptional control of the human plasma membrane phospholipid scramblase 1 gene is mediated by interferon-alpha","volume":"95","author":"Sims","year":"2000","journal-title":"Blood"},{"key":"28","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1182\/blood-2004-04-1630","article-title":"Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation","volume":"104","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.abb.2007.04.002","article-title":"Phospholipid scramblases: an overview","volume":"462","author":"Aradhyam","year":"2007","journal-title":"Archives of biochemistry and biophysics"},{"key":"30","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.0803050","article-title":"A novel hybrid yeast-human network analysis reveals an essential role for FNBP1L in antibacterial autophagy","volume":"182","author":"Xavier","year":"2009","journal-title":"J Immunol"},{"key":"31","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1158\/0008-5472.CAN-10-2889","article-title":"eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206","volume":"71","author":"Yang","year":"2011","journal-title":"Cancer research"},{"key":"32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cellsig.2013.11.028","article-title":"The role of cell signalling in the crosstalk between autophagy and apoptosis","volume":"26","author":"Dent","year":"2014","journal-title":"Cellular signalling"},{"key":"33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Agnello","year":"2016","journal-title":"Autophagy"},{"key":"34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Kepp","year":"2014","journal-title":"Nature medicine"},{"key":"35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4161\/15548627.2014.994368","article-title":"Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia","volume":"11","author":"Ju","year":"2015","journal-title":"Autophagy"},{"key":"36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4149\/neo_2015_025","article-title":"Autophagy facilitates multidrug resistance development through inhibition of apoptosis in breast cancer cells","volume":"62","author":"Cai","year":"2015","journal-title":"Neoplasma"},{"key":"37","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bcp.2014.12.003","article-title":"Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells","volume":"93","author":"Agostinis","year":"2015","journal-title":"Biochemical pharmacology"},{"key":"38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4161\/auto.19050","article-title":"FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma: is FTY720 the next autophagy-blocking agent in lymphoma treatment?","volume":"8","author":"Praetorius-Ibba","year":"2012","journal-title":"Autophagy"},{"key":"39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4149\/neo_2015_047","article-title":"17-AAG enhances the cytotoxicity of flavopiridol in mantle cell lymphoma via autophagy suppression","volume":"62","author":"Guan","year":"2015","journal-title":"Neoplasma"},{"key":"40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2119\/molmed.2010.00115","article-title":"Identification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancer","volume":"17","author":"Chan","year":"2011","journal-title":"Mol Med"},{"key":"41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1499-3872(12)60197-0","article-title":"Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer","volume":"11","author":"An","year":"2012","journal-title":"Hepatobiliary & pancreatic diseases international"},{"key":"42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/cbdd.12347","article-title":"Antibody against N-terminal domain of phospholipid scramblase 1 induces apoptosis in colorectal cancer cells through the intrinsic apoptotic pathway","volume":"84","author":"Chan","year":"2014","journal-title":"Chemical biology & drug design"},{"key":"43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/jcp.2010.079525","article-title":"Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas","volume":"63","author":"Sivridis","year":"2010","journal-title":"Journal of clinical pathology"},{"key":"44","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jclinpath-2014-202529","article-title":"The significance of autophagy in colorectal cancer pathogenesis and implications for therapy","volume":"67","author":"Lee","year":"2014","journal-title":"Journal of clinical pathology"},{"key":"45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cgh.2015.04.097","article-title":"High expression of Beclin-1 predicts favorable prognosis for patients with colorectal cancer","volume":"39","author":"Wang","year":"2015","journal-title":"Clinics and research in hepatology and gastroenterology"},{"key":"46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-4598-12-32","article-title":"Phospholipid Scramblase 1, an interferon-regulated gene located at 3q23, is regulated by SnoN\/SkiL in ovarian cancer cells","volume":"12","author":"Nanjundan","year":"2013","journal-title":"Molecular cancer"},{"key":"47","doi-asserted-by":"crossref","first-page":"e1510","DOI":"10.1038\/cddis.2014.468","article-title":"Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation","volume":"5","author":"Lai","year":"2014","journal-title":"Cell death & disease"},{"key":"48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1182\/asheducation-2009.1.523","article-title":"The 2008 WHO classification of lymphomas: implications for clinical practice and translational research","author":"Jaffe","year":"2009","journal-title":"Hematology\/American Society of Hematology Education Program"},{"key":"49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/0008-5472.587.65.2","article-title":"Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma","volume":"65","author":"Dolcetti","year":"2005","journal-title":"Cancer research"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T18:17:02Z","timestamp":1656613022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":49,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2106,7,5]]}},"alternative-id":["9630","27248824"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9630","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}